Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07257133 · ClinicalTrials.gov registry record · Phase 4
A Study Of Opioid Avoidance In Surgery Through Integrating Suzetrigine
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT07257133: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT07257133 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07257133, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
This prospective, single-arm feasibility study will evaluate postoperative pain control, opioid use, and early recovery outcomes in adult patients undergoing elective outpatient facial plastic surgery who receive suzetrigine as part of their standard postoperative analgesic regimen.
Interventions
- DRUG Suzetrigine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-10-20 |
| Est. Completion | 2026-04-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07257133
The ClinicalTrials.gov registry entry for NCT07257133 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Suzetrigine is the first listed.
NCT07257133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07257133 about?
NCT07257133 is a clinical study titled "A Study Of Opioid Avoidance In Surgery Through Integrating Suzetrigine". This prospective, single-arm feasibility study will evaluate postoperative pain control, opioid use, and early recovery outcomes in adult patients undergoing elective outpatient facial plastic surgery who receive suzetrigine as part of their standard postoperative analgesic regimen.
What is the current status of trial NCT07257133?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2025-10-20. Estimated completion is 2026-04-01.
What interventions are being tested in trial NCT07257133?
The interventions under investigation include: Suzetrigine (DRUG).
Who is sponsoring clinical trial NCT07257133?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.